EUVIMEDEUVIMED entdecken
Crossref

Tiliroside attenuates acute kidney injury by inhibiting ferroptosis through the disruption of NRF2-KEAP1 interaction

Fangfang Cai, Dangran Li, Kaiqian Zhou, Wen Zhang, Yunwen Yang

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155407 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Fangfang Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China. Hauptthemen laut MEDLINE: Ferroptosis, Acute Kidney Injury. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Jiangsu Province Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ferroptosis, an iron-dependent process that regulates cell death. Emerging evidences suggest that ferroptosis induces acute kidney injury (AKI) progression, and inhibiting ferroptosis provides an effect strategy for AKI treatment. The disruption of the NRF2-KEAP1 protein to protein interaction (PPI) induces NRF2 activation, which provides a promising strategy that can identify new ferroptosis inhibitors. A previous study revealed that tiliroside, a glycosidic flavonoid extracted from Edgeworthia chrysantha Lindl (buds), has anti-neuroinflammatory and neuroprotective effects via NRF2 activation. However, the mechanism through which tiliroside activates NRF2 is unknown, and it remains unclear whether it has protective effects against AKI. PURPOSE: To investigate whether tiliroside has protective effects against AKI in mice and the associated mechanisms. METHODS: Possible tiliroside substrates were analyzed using molecular docking. Cisplatin- and ischemia-reperfusion injury (IRI)-induced AKI mouse models and HK2 cells model were constructed to evaluate the protective effects of tiliroside. CRISPR/Cas9 mediated NRF2 knockout HK2 cells were used to verify whether NRF2 mediates tiliroside protective effects. RESULTS: In vivo, our results showed that tiliroside treatment preserved kidney functions in AKI mice models, as showed by lower levels of serum creatinine (SCr), blood urea nitrogen (BUN), and renal injury markers, including neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM1), compared with the mice in control groups. In vitro, tiliroside treatment greatly ameliorated cisplatin-induced ferroptosis through NRF2 activation in cultured HK2 cells, as evidenced by the protective effects of tiliroside being greatly blunted after the knockout of NRF2 in HK2 cells. Mechanistic studies indicated that tiliroside promoted NRF2/GPX4 pathway activation and ferroptosis inhibition, perhaps via the disruption of the NRF2-KEAP1 PPI. CONCLUSION: Together, our results demonstrate that tiliroside may serve as a NRF2-KEAP1 PPI inhibitor and prevents ferroptosis-induced AKI, indicating its potential for clinical AKI treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisAcute Kidney InjuryAnimalsMiceKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2CisplatinMolecular Docking SimulationFlavonoids

Stichwörter der Autor:innen

Acute kidney injuryAntioxidantFerroptosisNRF2Tiliroside

Substanzen

tilirosideKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2CisplatinFlavonoids

Autor:innen und Institutionen

  • School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
  • The State Key Laboratory of Pharmaceutical Biotechnology, College of Life Sciences, Nanjing University, Nanjing, 210023, China.
  • Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing 210008, China.
  • Department of Nephrology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine.
  • Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing 210008, China. Electronic address: yangyunwen@njmu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province Natural Science Foundation

Zitieren

APA

Cai, F., Li, D., Zhou, K., Zhang, W., & Yang, Y. (2024). Tiliroside attenuates acute kidney injury by inhibiting ferroptosis through the disruption of NRF2-KEAP1 interaction. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155407

Vancouver

Cai F, Li D, Zhou K, Zhang W, Yang Y. Tiliroside attenuates acute kidney injury by inhibiting ferroptosis through the disruption of NRF2-KEAP1 interaction. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155407

BibTeX
@article{Cai2024,
  author = {Cai, Fangfang and Li, Dangran and Zhou, Kaiqian and Zhang, Wen and Yang, Yunwen},
  title = {Tiliroside attenuates acute kidney injury by inhibiting ferroptosis through the disruption of NRF2-KEAP1 interaction},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155407}
}
Kostenlos starten →